Milestone Pharmaceuticals Inc. (MIST) Social Stream
Milestone Pharmaceuticals Inc (MIST) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Milestone Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
MIST's average price target has moved up $9.6 over the prior 22 months.
Over the past 50 weeks, MIST's average upside potential has been 144.17%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MIST Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MIST's average broker recommendation rating improved by 0.1 over the prior 151 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Milestone Pharmaceuticals Inc's variance in analysts' estimates is lower than -167.27% of all US stocks.
- In terms of how Milestone Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is higher than 42.18% of that group.
- Milestone Pharmaceuticals Inc's number of analysts covering the stock is higher than 58.2% of all US stocks.
- In terms of how Milestone Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 106.05% of that group.
What is the outlook for MIST? Use POWR Ratings for clearer insight into price direction.